Edesa Biotech (EDSA) Change in Cash (2013 - 2025)

Edesa Biotech has reported Change in Cash for 13 years, with the latest figure at $1.3 million in Q4 2025.

• Quarterly Change in Cash rose 139.38% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.5 million (up 487.84% YoY) and the FY2025 annual result came in at $9.8 million, up 325.59% from the prior year.
• Change in Cash improved to $1.3 million in Q4 2025 per EDSA's latest filing, from -$1.6 million in the prior quarter.
• Over five years, Change in Cash peaked at $12.3 million in Q1 2025 and troughed at -$5.7 million in Q3 2022.
• A 5-year average of $287322.8 and a median of -$1.0 million in 2023 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2022 and 2025: Change in Cash slumped 2580.45% in 2022, then jumped 940.04% in 2025.
• Over 5 years, Change in Cash stood at -$2.0 million in 2021, then jumped by 160.21% to $1.2 million in 2022, then slumped by 192.73% to -$1.1 million in 2023, then jumped by 148.11% to $526182.0 in 2024, then surged by 139.38% to $1.3 million in 2025.
• According to Business Quant data, Change in Cash over the past three periods registered $1.3 million, -$1.6 million, and -$1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.